Open Access 2025 Webinar: ISCT SCA Industry Town hall: A Door for Development
-
Register
- Non-member - Free!
- Member - Free!
- Community Administrator - Free!
- Emeritus Member - Free!
- Industry Community - Free!
- Industry Community Sub Account - Free!
- Laboratory Member - Free!
- Laboratory Technologist Sub Account - Free!
- Laboratory Regular Member Sub Account - Free!
- Laboratory Resident and Fellow Sub Account - Free!
- Regular Member - Free!
- Resident or Fellow Member - Free!
- Student Member - Free!
- Technologist Member - Free!
The International Society for Cell & Gene Therapy (ISCT) is the leading global platform dedicated to advancing cell and gene therapies through collaboration between academia, industry, and regulatory bodies. By fostering meaningful connections and driving clinical translation, ISCT empowers innovation and the responsible commercialization of advanced therapies worldwide.
The upcoming ISCT SCA Industry Town Hall is a strategic initiative aimed at bridging the gap between industry stakeholders in South & Central America and the vast resources of ISCT. This focused session will explore shared challenges and emerging opportunities to accelerate development in the field.
Industry participants will hear directly from Vincenzo Di Cerbo, a member of the ISCT Industry Committee, who will outline the benefits of ISCT Industry Membership—including global networking, regulatory engagement, and collaboration platforms designed to drive progress.
Adding a regional spotlight, Dr. Maroun Khoury, Director of the IMPACT Center in Chile, will share insights from one of Latin America’s most active hubs in developing and translating cell and gene therapies. His perspective will highlight the critical role of local innovation and the importance of global integration through partnerships like those facilitated by ISCT.
This Town Hall offers a powerful space for connection, visibility, and strategic growth. It reaffirms ISCT’s commitment to supporting companies across the region as they navigate clinical, commercial, and regulatory pathways—and opens the door to a more connected, impactful future for CGT in Latin America and beyond.
KEY LEARNING OBJECTIVES
• Foster collaboration between Academia, Industry, and Regulatory stakeholders in the SCA region
• Address challenges related to clinical translation and commercialization to accelerate developments in the field
• Bridge the gaps between the cell and gene therapy industry and ISCT's resources
• Increase visibility of cell and gene therapy companies in the region
• Grow the membership of ISCT members in SCA
• Promote awareness and standardization of ethical practices in the field